Liposomal daunorubicin

Liposomal Daunorubicin

Liposomal daunorubicin (pronunciation: li-PO-so-mal daw-no-RU-bi-sin) is a chemotherapy drug used in the treatment of certain types of cancer, including HIV-related Kaposi's sarcoma and leukemia. It is a form of the drug daunorubicin that has been encapsulated in a liposome.

Etymology

The term "daunorubicin" is derived from the name of the bacterium Streptomyces peucetius var. caesius, from which the drug was originally isolated in the 1960s. The prefix "liposomal" refers to the drug's encapsulation in a liposome, a type of artificial vesicle.

Pharmacology

Liposomal daunorubicin works by intercalating into the DNA of cancer cells, preventing them from replicating and thus inhibiting their growth. The liposomal encapsulation allows the drug to be delivered directly to the cancer cells, reducing the side effects associated with traditional chemotherapy drugs.

Related Terms

• Chemotherapy
• Daunorubicin
• DNA
• HIV
• Kaposi's sarcoma
• Leukemia
• Liposome
• Streptomyces peucetius

See Also

• List of chemotherapy drugs
• List of HIV-related conditions
• List of cancer types

External links

• Medical encyclopedia article on Liposomal daunorubicin
• Wikipedia's article - Liposomal daunorubicin

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski